WuXi AppTec lays out five peptide manufacturing trends for 2026, pointing to oral dosing as the reason makers need far more active ingredient. It's a company press release.
Recap by typeshit. Full story at Yahoo Finance.
She describes MOTS-c as a messenger made by mitochondria that may help muscles handle sugar. The framing is hers and not an established health claim.
Medscape covers research tying GLP-1 drug use to lower alcohol consumption. Tap through for the study details and what researchers found.
In a small 2022 trial, whey beat leucine-boosted collagen for muscle growth, while evidence that collagen prevents sports injuries is still missing.
The orexin agonist, FDA approved in August, is being studied for ADHD and Parkinson's fatigue. Takeda's R&D head compares its reach to GLP-1 drugs, though data is early.
Stanford researchers found that blocking a protein could point toward a shot or pill that regrows cartilage, an idea Forbes compares to GLP-1 drugs.
Observational data link GLP-1 drugs to fewer cases of some cancers, but trials have yet to show they prevent cancer or help survival after a diagnosis.
Loading…